期刊文献+

植入物在青光眼术中的应用 被引量:1

下载PDF
导出
摘要 目前青光眼的滤过性手术是治疗青光眼的重要方法,但手术后2年的失败率仍达15~30%。其失败的主要原因是成纤维细胞增殖.胶原沉积.瘢痕形成而使滤过泡功能减退。为此国内外许多专家采用很多方法以减少滤过道瘢痕形成,如使用抗代谢药物,丝裂霉素-5-氟尿嘧啶等.这些药物虽可延缓瘢痕形成,但易引起较多的并发症。而使用植入物。如生物膜、羊膜等.可机械隔离巩膜瓣和巩膜床。避免或减少纤维粘连.保持滤过道通畅。现将这些植入物的性质及临床应用等情况作一综述。
作者 周艳 裴重刚
出处 《江西医药》 CAS 2008年第5期484-488,共5页 Jiangxi Medical Journal
  • 相关文献

参考文献24

  • 1him K,Krag S,Corydon L.Stretching capacity of copsulorhexis and nucleus delivery.J Cataract Refract Surg,1991,17:27
  • 2Shahan T,Grant D,Tootell M,et al.Oncothanin,a peptide from the alpha3 chain of type Ⅳ collagen,modifies endothelial cell function and inhibits angiogenesis.Connect Tissue Res,2004,45:151
  • 3Anwar M,Sayyad FE,Maghraby AE.Lens capsule inclusion in trabeculectomy with cataract extraction.J Cataract Refract Surg, 1997,23: 1103
  • 4肖键.晶状体前囊膜移植在青光眼小梁切除术中的应用[J].华夏医学,2004,17(6):963-965. 被引量:1
  • 5徐金华,卢奕,周行涛.晶状体前囊膜在青光眼白内障联合手术中的应用[J].中国实用眼科杂志,2003,21(5):347-349. 被引量:3
  • 6Trelford JD,Trelford-Sauder M The amnion in surgery, past and present.Am J Obstet Gynecol;1979,134(7):833
  • 7Solomon A, Rosenblatt M, Monroy D.et al.Suppression of interleukin 1 alpha and interleukin 1 beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix.Br J Ophthalmol, 2001,85(4) : 444
  • 8Kobayashi N,Kabuyama Y,Sasaki S et al.Suppression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea,2002,21( 1):62
  • 9Ma X,Li D,Tseng SCG.Cytokine expression by human corneal and limbal fibroblasts is modulated by amniotic membrane.Invest Ophthalmol Vis Sci, 1997,38(4) : 512
  • 10Tseng SC ,Li DQ,Ma X.cornea Suppression of transforming growth factor-beta isoforms,TGF-beta receptor type Ⅱ, and myofibroblast differentiation in cultured human 1 and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol,1999,179(3):325

二级参考文献30

  • 1吴瑜瑜.青光眼引流性植入物的研究进展[J].国外医学(眼科学分册),1996,20(4):228-232. 被引量:13
  • 2钟一声.青光眼滤过性手术中联合应用抗代谢药物后低眼压性黄斑病变[J].国外医学(眼科学分册),1997,21(1):14-18. 被引量:10
  • 3[1]Melamed S,Fiore P.Molteno implant surgery in refractory glaucoma[J].Surv Ophthalmol,1990,34:441.
  • 4[2]Kim DM,Lim KH.Aqueous shumts single-plate molteno vs ACTSEB[J].Acta Ophthalmol Scand,1995,73:277-280.
  • 5[3]Thim K,Krag S,Corydon L.Stretching capacity of copsulorhexis and nucleus delivery[J].J Cataract Refract Surg,1991,17:27.
  • 6[4]Fritz WL.Fluorescein blue,light-assisted capsulorhexis for mature or hypemature cataract[J].J Cataract Refract Surg,1998,24:19-20.
  • 7[6]Melles GRJ,Waard PW,Pameyer JH,et al.Trypan blue capsule staining to visualize the capsulorhexis in catarct surgery[J].J Cataract Refract Surg,1999,25:7-9.
  • 8[7]Horiguchi M,Mivake K,Ohta I.Staining of the lens capsule for circlar continuous capsulorhexis in eyes with white cataract[J].Arch Ophthlmol,1998,116:535-537.
  • 9[8]Blumenthal M,Assia E,Neumann D.The round capsulorhexis capsulotomy and rationale for 11.0mm diameter IOL[J].Eur J Implant Refract Surg,1990,2:15.
  • 10[9]Davison JA.Capsule contraxtion syndome[J].J Catarct Refract Suyg,1993,19:582-589.

共引文献52

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部